Shz Salubris Pharma

Shenzhen Salubris Pharma is a manufacturer with phase III trials in hypertension (Sacubitril‑Allisartan), renal anemia (Enarodustat), and osteoporosis (SAL056/001/023), plus a growing portfolio of cardiovascular, anti‑diabetic and oncology products.

Headquarters: China (CHN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 3,596
HQ: Shenzhen

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
002294	Shz Salubris Pharma Cap: 54.8B \| P/E: 81.9	EQUITY	SHZ	CNY	CNE100000FW8	Active	📈